Stay updated on Dupilumab for Chronic Hands Eczema - Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.

Latest updates to the Dupilumab for Chronic Hands Eczema - Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAn NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error for the study record, replacing the previous content with an access-denied message and standard site chrome; the study details are no longer visible in this view.SummaryDifference18%

- Check48 days agoChange DetectedThe page now shows Revision: v3.7.0 to reflect the latest document version, and the older Revision: v3.6.6 label has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision has moved from v3.6.5 to v3.6.6, indicating a newer build of the page. This typically reflects minor fixes or improvements rather than changes to the displayed study information.SummaryDifference0.1%

- Check69 days agoChange DetectedAn NIH grant/contract entry for 2018 was added to the study's funding/identifiers section, indicating U.S. NIH support for this trial.SummaryDifference0.1%

Stay in the know with updates to Dupilumab for Chronic Hands Eczema - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.